TP53 and non-small cell lung carcinoma: Collectively, these results highlight the central role of XPO1 in modulating tumor suppressor activity and suggest that nuclear export inhibition represents a multifaceted strategy to overcome both p53-dependent and -independent mechanisms of NSCLC progression.